CIK 0001681682
- Non-accelerated filer
- Smaller reporting company
ENDRA Life Sciences Inc.
Sign in to watch- Ticker
- NDRA
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 260579295
- Phone
- +1 734-335-0468
- Business address
- 3600 GREEN COURT, SUITE 350, ANN ARBOR, MI, 48105
- Former names
- Endra Inc.
- 4 Grant or award Chief Commercial Officer acquired 86,580 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 79,653 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 96,213 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 123,064 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 100,503 shares (grant or award)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at $1.18 ($11,800)
- 4 Open-market buy Chief Financial Officer bought 10,000 shares at an average $1.56 ($15,550)
Page 6 of 9 · 174 filings